Skip to content

Chest symptoms that call for action

Reducing time to presentation with symptoms of lung cancer: phase II complex intervention study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN22421875
Enrollment
210
Registered
2009-04-08
Start date
2007-08-01
Completion date
Unknown
Last updated
2018-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer (and other lung diseases) Cancer Malignant neoplasm of the lung

Interventions

A complex intervention to be delivered in two general practices (rural and urban), targeted at 210 high risk patients (greater than 55 years, smokers and ex-smokers). The intervention has been develop

Sponsors

University of Aberdeen (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Long-term smokers (at least 20 pack years) aged 55 years or over, either sex, including ex-smokers if their cessation date is within 10 years

Exclusion criteria

Exclusion criteria: 1. Housebound 2. Terminally ill 3. Have dementia

Design outcomes

Primary

MeasureTime frame
Proportions of participants consulting within a week of haemoptysis or four weeks of other guideline symptoms (symptoms recommended for investigation in SIGN or Cancer Research UK guidelines on lung cancer) during the six-month period of follow up.

Secondary

MeasureTime frame
Measured by postal questionnaire at baseline, one month and six months: 1. Intentions to consult under various conditions - using methods found to give valid and reliable results 2. Self efficacy - questions adapted from standard measures, taking account of barriers to consultation identified during focus groups 3. Knowledge of symptoms and risk factors - using questions developed during our previous study 4. Cancer worry scale - a six-item scale found to have good reliability (most recently Cronbach's a = 0.83 and test-retest reliability = 0.74) 5. Hospital Anxiety and Depression questionnaire Measured at other timepoints: 6. Reasons for consultation will be investigated using short questionnaires after each consultation (explanations for symptoms considered, expectations from consultation, prompts received to consult, and resources used to decide) 7. Health service use (general practice consultations, and chest X-ray and hospital referrals/appointments) will be collected from general practice case notes at the end of the study period 8. Trial process outcomes. Recruitment rates, response rates, and problems encountered during recruitment, implementation of the intervention, and data collection will be noted throughout the course of the study.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026